Shay Capital LLC Humacyte, Inc. Transaction History

Shay Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.57 - $4.84 $84,689 - $159,492	-32,953 Reduced 35.51%	59,858 $186,000
Q4 2023 Feb 14, 2024	BUY	$1.99 - $3.12 $55,124 - $86,427	27,701 Added 42.54%	92,811 $263,000
Q3 2023 Nov 14, 2023	BUY	$2.75 - $4.48 $40,903 - $66,635	14,874 Added 29.61%	65,110 $190,000
Q2 2023 Aug 14, 2023	BUY	$2.86 - $4.97 $86,512 - $150,337	30,249 Added 151.34%	50,236 $143,000
Q1 2023 May 15, 2023	SELL	$2.11 - $3.25 $1,424 - $2,193	-675 Reduced 3.27%	19,987 $61,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.62 $41,737 - $74,796	20,662 New	20,662 $43,000

149

35.1M

279K

607K

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $472M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.